Showing results (141-150 of 155) with videos related to

Sort By:
Pageof 16
Open Forum Infectious Diseases|September 4, 2024
Evaluation of Factors Predictive of Efficacy Among Patients With Complicated Urinary Tract Infection and/or Acute PyelonephritisSujata M Bhavnani, Jeffrey P Hammel, Christopher M Rubino, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 30, 2018
Levofloxacin Pharmacokinetics/Pharmacodynamics, Dosing, Susceptibility Breakpoints, and Artificial Intelligence in the Treatment of Multidrug-resistant TuberculosisDevyani Deshpande, Jotam G Pasipanodya, Stellah G Mpagama, et al.
Antimicrobial Agents and Chemotherapy|November 27, 2019
Polymyxin Susceptibility Testing and Interpretive Breakpoints: Recommendations from the United States Committee on Antimicrobial Susceptibility Testing (USCAST)Jason M Pogue, Ronald N Jones, John S Bradley, et al.
Antimicrobial Agents and Chemotherapy|September 18, 2013
Pharmacological basis of β-lactamase inhibitor therapeutics: tazobactam in combination with CeftolozaneBrian Vanscoy, Rodrigo E Mendes, Jennifer McCauley, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 30, 2018
Gatifloxacin Pharmacokinetics/Pharmacodynamics-based Optimal Dosing for Pulmonary and Meningeal Multidrug-resistant TuberculosisDevyani Deshpande, Jotam G Pasipanodya, Shashikant Srivastava, et al.
Antimicrobial Agents and Chemotherapy|February 11, 2010
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis modelStanley C Gill, Christopher M Rubino, Jennifer Bassett, et al.
Antimicrobial Agents and Chemotherapy|November 5, 2014
Pharmacokinetic-pharmacodynamic analysis for efficacy of ceftaroline fosamil in patients with acute bacterial skin and skin structure infectionsSujata M Bhavnani, Jeffrey P Hammel, Scott A Van Wart, et al.
Antimicrobial Agents and Chemotherapy|September 28, 2023
Impact of antibiotic pharmacokinetics in urine on recurrent bacteriuria following treatment of complicated urinary tract infectionsDavid Melnick, Angela K Talley, Vipul K Gupta, et al.
Antimicrobial Agents and Chemotherapy|May 15, 2013
Pharmacokinetic-pharmacodynamic determinants of oseltamivir efficacy using data from phase 2 inoculation studiesC R Rayner, C C Bulik, M A Kamal, et al.
Open Forum Infectious Diseases|November 28, 2025
Evaluation of Aminoglycoside Dosing Regimens Adjusted for Renal Function and In Vitro Susceptibility Test Interpretive Criteria for Enterobacterales and Pseudomonas aeruginosa: Brief SummarySujata M Bhavnani, Jeffrey P Hammel, Nikolas J Onufrak, et al.
Pageof 16